Cargando…

Safety of antivascular endothelial growth factor administration in the ocular anterior segment in pterygium and neovascular glaucoma treatment: Systematic review and meta-analysis

BACKGROUND: Anti-VEGF agents has been widely used in ocular diseases, but its safety for treating anterior segment disorders, the conclusions are controversial. METHODS: Several major databases, including CENTRAL, MEDLINE, and EMBASE, were searched. Safety data from 18 randomized controlled trials (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Shi-tong, Tian, Bi-shan, Xiao, Ou, Yang, Yong-juan, Zhou, Shi-you
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112962/ https://www.ncbi.nlm.nih.gov/pubmed/30142821 http://dx.doi.org/10.1097/MD.0000000000011960

Ejemplares similares

Antivascular Endothelial Growth Factor Agents for Neovascular Age-Related Macular Degeneration
por: Zampros, Ilias, et al.
Publicado: (2012)

The Effect of Antivascular Endothelial Growth Factor Therapy on the Development of Neovascular Glaucoma after Central Retinal Vein Occlusion: A Retrospective Analysis
por: Ryu, Christina L., et al.
Publicado: (2014)

Antiangiogenic drugs in the management of ocular diseases: Focus on antivascular endothelial growth factor
por: Sassa, Yukio, et al.
Publicado: (2010)

Role of Intravitreal Antivascular Endothelial Growth Factor Injections for Choroidal Neovascularization due to Choroidal Osteoma
por: Mansour, Ahmad M., et al.
Publicado: (2014)

Clinical characteristics and antivascular endothelial growth factor effect of choroidal neovascularization in younger patients in Taiwan
por: Li, Yi-Hsuan, et al.
Publicado: (2015)

Ocular Decompression Retinopathy after Anterior Chamber Paracentesis for Neovascular Glaucoma
por: Tsai, Yung-En, et al.
Publicado: (2021)

Quantitative physiological measurements to evaluate the response of antivascular endothelial growth factor treatment in patients with neovascular diseases
por: Hong, In Hwan, et al.
Publicado: (2017)

Ten-year outcomes of antivascular endothelial growth factor therapy in neovascular age-related macular degeneration
por: Chandra, Shruti, et al.
Publicado: (2020)

Comparison of ocular surface squamous neoplasia and pterygium using anterior segment optical coherence tomography angiography
por: Nampei, Kanako, et al.
Publicado: (2020)

Bilateral choroidal neovascularization associated with optic nerve head drusen treated by antivascular endothelial growth factor therapy
por: Delas, Barbara, et al.
Publicado: (2012)

Anterior segment changes following intravitreal bevacizumab injection for treatment of neovascular glaucoma
por: Canut, MI, et al.
Publicado: (2011)

ASSOCIATION BETWEEN ANATOMICAL AND CLINICAL OUTCOMES OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED WITH ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR
por: Nguyen, Vuong, et al.
Publicado: (2021)

Bevacizumab (Avastin(®)) for the management of anterior chamber neovascularization and neovascular glaucoma
por: Brouzas, Dimitrios, et al.
Publicado: (2009)

Commentary: Antivascular endothelial growth factor and retinopathy of prematurity
por: Dudani, Ajay Indur, et al.
Publicado: (2019)

Use of antivascular endothelial growth factor for diabetic macular edema
por: Karim, Rushmia, et al.
Publicado: (2010)

Efficacy and Safety of Antivascular Endothelial Growth Factor (Anti-VEGF) in Treating Neovascular Age-Related Macular Degeneration (AMD): A Systematic Review and Meta-analysis
por: Yin, Xiaobei, et al.
Publicado: (2022)

Concurrent management of myopic choroidal neovascularization and rhegmatogenous retinal detachment with intravitreal antivascular endothelial growth factor during primary retinal detachment repair
por: Saurabh, Kumar, et al.
Publicado: (2018)

Vascular Endothelial Growth Factor in Anterior Chamber Liquid Patients with Diabetic Retinopathy, Cataract and Neovascular Glaucoma
por: Kuzmin, Anatoly, et al.
Publicado: (2013)

Intravitreal Bevacizumab (Avastin) Treatment of Neovascular Glaucoma in Ocular Ischemic Syndrome
por: Lee, Sang Joon, et al.
Publicado: (2009)

Clinical Features of Ocular Ischemic Syndrome and Risk Factors for Neovascular Glaucoma
por: Kim, Yung Hui, et al.
Publicado: (2017)

Real-world outcomes of intravitreal antivascular endothelial growth factors for neovascular age-related macular degeneration in Taiwan: A 4-year longitudinal study
por: Yang, Benjamin Chi-Lan, et al.
Publicado: (2019)

Repeated intravitreal injections of antivascular endothelial growth factor in patients with neovascular age-related macular degeneration may increase the risk of ischemic optic neuropathy
por: Chen, Yu-Yen, et al.
Publicado: (2019)

Impact of pterygium on the ocular surface and meibomian glands
por: Wanzeler, Ana Claudia Viana, et al.
Publicado: (2019)

Research on an Intelligent Lightweight-Assisted Pterygium Diagnosis Model Based on Anterior Segment Images
por: Zheng, Bo, et al.
Publicado: (2021)

Effects of Smoking on Outcomes of Antivascular Endothelial Growth Factor Therapy in Patients with Neovascular Age-Related Macular Degeneration Smoking and Anti-VEGF Therapy in nAMD
por: Kamao, Hiroyuki, et al.
Publicado: (2018)

Ten-year real-world outcomes of antivascular endothelial growth factor therapy in neovascular age-related macular degeneration using pro re nata regimen
por: Hujanen, Pekko, et al.
Publicado: (2023)

Neovascularization and mast cells with tryptase activity increase simultaneously in human pterygium
por: Ribatti, Domenico, et al.
Publicado: (2007)

Wound Healing Modulation in Glaucoma Filtration Surgery– Conventional Practices and New Perspectives: Antivascular Endothelial Growth Factor and Novel Agents (Part II)
por: Fan Gaskin, Jennifer C, et al.
Publicado: (2014)

Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-11
por: Wildiers, H, et al.
Publicado: (2003)

The Use of Antivascular Endothelial Growth Factor Agents in the Perioperative Period in Diabetic Vitrectomy
por: Abu-Yaghi, Nakhleh E., et al.
Publicado: (2012)

Resistance to antivascular endothelial growth factor treatment in age-related macular degeneration
por: Tranos, Paris, et al.
Publicado: (2013)

Promising Novel Treatment against Keloids: Antivascular Endothelial Growth Factor Agents
por: Abtahi-Naeini, Bahareh, et al.
Publicado: (2019)

Iris Morphological Features in Patients with 360° Angle-Closure Neovascular Glaucoma: An Anterior Segment Optical Coherence Tomography Study
por: Kobayashi, Yui, et al.
Publicado: (2018)

Anterior Segment Neovascularization in Diabetic Retinopathy: A Masquerade
por: Cheng, Yong, et al.
Publicado: (2015)

Vascular Endothelial Growth Factors and Their Inhibitors in Ocular Neovascular Disorders
por: Homayouni, Mansour
Publicado: (2009)

A case of spontaneous avulsion of primary pterygium analyzed with anterior segment optical coherence tomography
por: Tanaka, Takayuki, et al.
Publicado: (2022)

Sensory Changes in the Ocular Surface After Pterygium Removal
por: Esa, Saleh, et al.
Publicado: (2023)

Induction of endothelial RAGE expression in pterygium
por: Al-Swailem, Samar, et al.
Publicado: (2014)

Antivascular Therapy for Epithelial Ovarian Cancer
por: Duhoux, Francois P., et al.
Publicado: (2010)

Morphometric evaluation and measurements of primary pterygium by anterior segment optical coherence tomography and its relation with astigmatism
por: Raj, Anuradha, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s4jihk0j6r0r1410evv0k13eno